|
|
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received for publication August 8, 2006.
Revised March 29, 2007.
Accepted for publication March 30, 2007.
signaling reduces pancreatic adenocarcinoma growth and invasiveness
Transforming growth factor
(TGF
) is a pleiotropic factor that regulates cell proliferation, angiogenesis, metastasis, and immune suppression. Dysregulation of the TGF
pathway in tumor cells often leads to resistance to the anti-proliferative effects of TGF
while supporting other cellular processes that promote tumor invasiveness and growth. In the present study SD-208, a small molecule, ATP-competitive inhibitor of the TGF
receptor I kinase (TGF
RI), was used to inhibit cellular activities and tumor progression of PANC-1, a human pancreatic tumor line. SD-208 blocked TGF
-dependent Smad2 phosphorylation and expression of TGF
-inducible proteins in cell culture. cDNA microarray analysis and functional gene clustering identified groups of TGF
-regulated genes involved in metastasis, angiogenesis, cell proliferation, survival, and apoptosis. These gene responses were inhibited by SD-208. Using a Boyden chamber motility assay, we demonstrated that SD-208 inhibited TGF
-stimulated invasion in vitro. An orthotopic xenograft mouse model revealed that SD-208 reduced primary tumor growth and decreased the incidence of metastasis in vivo. Our findings suggest mechanisms through which TGF
signaling may promote tumor progression in pancreatic adenocarcinoma. Moreover, they suggest that inhibition of TGF
RI with a small molecule inhibitor may be effective as a therapeutic approach to treat human pancreatic cancer.
Key words:
Insulin, Ras, MAP Kinase, Regulation of gene expression, Apoptosis, Mechanisms of cell killing/apoptosis, Metastasis, Oncogenes, Tumor suppressors, Angiogenesis
This article has been cited by other articles:
![]() |
L. Zhou, A. N. Nguyen, D. Sohal, J. Ying Ma, P. Pahanish, K. Gundabolu, J. Hayman, A. Chubak, Y. Mo, T. D. Bhagat, et al. Inhibition of the TGF-{beta} receptor I kinase promotes hematopoiesis in MDS Blood, October 15, 2008; 112(8): 3434 - 3443. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Zaiman, M. Podowski, S. Medicherla, K. Gordy, F. Xu, L. Zhen, L. A. Shimoda, E. Neptune, L. Higgins, A. Murphy, et al. Role of the TGF-{beta}/Alk5 Signaling Pathway in Monocrotaline-induced Pulmonary Hypertension Am. J. Respir. Crit. Care Med., April 15, 2008; 177(8): 896 - 905. [Abstract] [Full Text] [PDF] |
||||